Skip to main content

Guidance

Pre- and Post-Exposure Prophylaxis Guidelines (HIV)


PEP
 (Post-Exposure Prophylaxis)

PrEP (Pre-Exposure Prophylaxis)

HIV/AIDS Clinical Guidelines
(U.S. Department of Health and Human Services)
These federally approved medical practice guidelines for HIV/AIDS are developed and updated by panels of HIV care experts. Following are selected USDHHS guidelines of interest. 

 

Antiretroviral Agents
Care for People with HIV Displaced by Disasters
Contraception for HIV High-Risk or Infected Women
Opportunistic Infections
Prevention
Testing

Guidelines for Testing and Reporting: Perinatal Human Immunodeficiency Virus (HIV), Hepatitis B, Hepatitis C, and Syphilis
(Michigan Department of Health and Human Services, rev. September 2021)

Physicians and other health care professionals providing medical treatment to birthing people are required, at the time of initial prenatal screening and examination, and during the third trimester, and at delivery in absence of previous testing results to test for HIV, hepatitis B, hepatitis C, and syphilis, unless the birthing person refuses to be tested or the provider deems the tests are medically inadvisable. These guidelines are for healthcare professionals working in prenatal care, labor and delivery, and emergency services.

 

Guidance for HIV Self-Testing Program Implementation and Data Reporting
(Michigan Department of Health and Human Services, rev. February 2022)

This document provides guidance on the creation of policies and procedures for program implementation and data entry for the HIV rapid self-administered over-the-counter (OTC) test (HIVST or rapid HIV self-test). This guidance is intended for use by programs funded or otherwise supported by MDHHS.

 

Primary Care Guidance for Persons With Human Immunodeficiency Virus: 2020 Update
(HIV Medicine Association of the Infectious Diseases Society of America, 2020)

This evidence-based guidance for the primary care of people living with human immunodeficiency virus (HIV) is intended for use by healthcare providers who care for people living with HIV. Every 12 to 18 months following publication, IDSA reviews its guidelines to determine whether an update is required. This guidance was published in November of 2020 as an update to the 2013 guidelines.

 

Recommendations for Conducting Integrated Partner Services for HIV/STI Prevention
(Michigan Department of Community Health, 2011)

These recommendations were developed to articulate standards for providing partner services in Michigan for HIV, early syphilis, gonorrhea, and chlamydia and guide and inform the provision of such services.

 

2021 Sexually Transmitted Infections Treatment Guidelines
(Centers for Disease Control and Prevention)

Physicians and other health care providers can use these guidelines to assist in prevention and treatment of STIs. The new guidelines include notable updates from the previous 2015 guidance, including:

  • updated treatment recommendations for chlamydia, trichomoniasis, and pelvic inflammatory disease;
  • updated treatment recommendations for uncomplicated gonorrhea in neonates, children, and other specific clinical situations (e.g., proctitis, epididymitis, sexual assault), which builds on broader treatment changes published in Morbidity and Mortality Weekly Report;
  • information on FDA-cleared diagnostic tests for Mycoplasma genitalium and rectal and pharyngeal chlamydia and gonorrhea;
  • expanded risk factors for syphilis testing among pregnant patients;
  • recommended two-step serologic testing for diagnosing genital herpes simplex virus;
  • harmonized recommendations for human papillomavirus vaccination with the Advisory Committee on Immunization Practices; and
  • recommended universal hepatitis C testing in alignment with CDC's 2020 hepatitis C testing recommendations.

STD Program Management & Evaluation Tools
(Centers for Disease Control and Prevention)